Anemia in children arises from a complex interplay of nutritional, infectious, genetic and socio-environmental factors. Inadequate dietary intake of iron and other micronutrients such as vitamin A, ...

Please provide your email address to receive an email when new articles are posted on . AUSTIN, Texas — Incorporating electronic medical record-activated alerts in a pediatric inflammatory bowel ...

The approval was based on an open-label, multiple dose, multicenter, dose-finding study in 64 pediatric patients with CKD who were on hemodialysis and who had stable hemoglobin levels while previously ...

Credit: Getty Images. Injectafer is an iron replacement product. The Food and Drug Administration (FDA) has expanded the approval of Injectafer ® (ferric carboxymaltose injection) to include patients ...

Lactoferrin is an effective therapy for children with anemia of CKD. Both oral lactoferrin and intravenous iron dextran can effectively treat anemia of chronic kidney disease (CKD) in children, ...

Retinopathy of prematurity (ROP) is a major cause of vision impairment in preterm infants, particularly those born weighing ≤1,250 g. Anemia is commonly observed in these infants, with nearly 90% of ...

In paediatric kidney transplant recipients with iron deficiency, with or without anaemia, intravenous ferric carboxymaltose therapy was safe and led to significant increases in haemoglobin levels at ...

Orlando, Florida — Stroke is a devastating complication of sickle cell anemia that occurs in young children, and while blood transfusions protect against primary stroke, they must be continued ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Akebia Therapeutics recently updated its ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Akebia Therapeutics has initiated a study ...

Akebia Therapeutics ((AKBA)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...